1256  SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19.

1255  Nociceptors protect sickle cell disease mice from vaso-occlusive episodes and chronic organ damage.

1254  TGF-β suppresses type 2 immunity to cancer.

1253  Autoantibodies against type I IFNs in patients with life-threatening COVID-19.

1252  A large immunological and genomics study of COVID-19 patients reveals excess mutations in the type I IFN pathway.

1251  Mammalian lipid droplets are innate immune hubs integrating cell metabolism and host defense.

1250  A SARS-CoV-2 mouse model is used to study viral responses and the development of vaccine candidates.

1249  Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment.

1248  Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19.

1247  The bacterial-derived metabolite inosine enhances cancer immunotherapy in mice.

Free Images for Presentation: sunipix SUNIPIX